Mond to Frid from 8:30 till 20:00
admin@peptworld.com
+351 964 943 024
en
Cart
0
0.00 €

FOX04 Dri 10mg

Out of stock

FOXO4-DRI is a synthetic senolytic peptide designed to selectively eliminate senescent cells—often referred to as "zombie cells"—which accumulate with age and contribute to tissue dysfunction. By disrupting a specific protein interaction, it triggers programmed cell death (apoptosis) in these damaged cells while leaving healthy cells unharmed.

Mechanism of Action:

Senescent cells survive by keeping the "pro-death" protein p53 sequestered in the nucleus via the transcription factor FOXO4.

  • Targeted Disruption: FOXO4-DRI mimics a portion of the FOXO4 protein, acting as a competitive inhibitor that blocks the FOXO4-p53 interaction.
  • Inducing Apoptosis: Once p53 is released from FOXO4, it exits the nucleus and moves to the mitochondria, where it triggers the cell's internal self-destruction pathway.
  • D-Retro-Inverso (DRI) Design: The peptide is built using "D-amino acids" in a reversed sequence (retro-inverso), which makes it resistant to natural enzymes and significantly more stable in the body. 

Potential Benefits (Research Findings)While primarily studied in animal models (mice), research indicates several potential regenerative effects:

  • Testosterone & Fertility: It has been shown to eliminate senescent Leydig cells in the testes, which can restore natural testosterone production and improve sperm quality in aged mice.
  • Physical Rejuvenation: In "fast-aging" mouse models, it improved fur density, renal (kidney) function, and overall physical activity/fitness levels.
  • Vascular Health: Studies suggest it can improve vascular elasticity and reduce inflammation in the aorta by clearing senescent endothelial cells.
  • Chemotoxicity: It has demonstrated the ability to neutralize liver damage and weight loss caused by certain chemotherapy drugs like doxorubicin. 

Status and Availability

  • Regulatory Status: FOXO4-DRI is not FDA-approved for human use and is currently classified as an investigational compound intended for scientific research.

  • Research Use: It is widely sold by chemical supply companies for laboratory experiments only.

  • Safety: Human safety data is extremely limited. While early animal studies suggested it was well-tolerated, potential side effects such as muscle damage or cardiotoxicity require further investigation before clinical translation.
240.00 €
240.00 € / 10 g

FOXO4-DRI Peptide: Senolytic Research, Cellular Aging and Longevity Science

What Is FOXO4-DRI?

FOXO4-DRI is a synthetic senolytic peptide developed to selectively target and eliminate senescent cells, often referred to as "zombie cells." These dysfunctional cells accumulate with aging and are associated with chronic inflammation, tissue degeneration, and age-related decline.

The peptide has gained significant scientific attention in longevity and regenerative medicine research due to its unique ability to induce apoptosis specifically in senescent cells while leaving healthy cells largely unaffected.

FOXO4-DRI is currently explored in research focused on cellular aging, tissue rejuvenation, vascular health, and regenerative biology.

How FOXO4-DRI Works

Senescent cells resist natural cell death by trapping the pro-apoptotic protein p53 within the nucleus through interaction with the FOXO4 transcription factor.

Targeted FOXO4-p53 Disruption

FOXO4-DRI was designed to interfere with the FOXO4-p53 interaction by acting as a competitive inhibitor.

Once this interaction is disrupted:

  • p53 is released from the nucleus
  • Cellular self-destruction pathways are activated
  • Senescent cells undergo apoptosis

This selective mechanism has made FOXO4-DRI one of the most studied senolytic peptides in modern aging research.

D-Retro-Inverso (DRI) Technology

FOXO4-DRI utilizes a specialized D-retro-inverso peptide design.

This involves:

  • Reversed amino acid sequence
  • Use of D-amino acids instead of natural L-amino acids

Potential advantages include:

  • Increased stability
  • Improved resistance to enzymatic degradation
  • Extended biological activity
  • Enhanced peptide durability in research models

Potential Research Areas of FOXO4-DRI

1. Cellular Senescence and Aging Research

Senescent cells accumulate naturally with age and contribute to:

  • Chronic inflammation
  • Tissue dysfunction
  • Reduced regenerative capacity
  • Biological aging

Research involving FOXO4-DRI investigates its potential role in selectively clearing these dysfunctional cells to support healthier tissue environments.

2. Longevity and Regenerative Science

FOXO4-DRI has become an important compound within longevity research due to its proposed senolytic effects.

Scientific interest includes:

  • Biological age reduction
  • Cellular rejuvenation
  • Tissue regeneration
  • Healthspan extension
  • Age-related degeneration research

Animal models continue to explore the relationship between senescent cell clearance and healthy aging.

3. Testosterone and Fertility Research

Preclinical studies involving aged animal models suggest FOXO4-DRI may help eliminate senescent Leydig cells within the testes.

Research observations include:

  • Restoration of natural testosterone production
  • Improved sperm quality
  • Enhanced reproductive cellular function

These findings remain under active investigation in laboratory settings.

4. Vascular and Cardiovascular Research

Senescent endothelial cells are strongly associated with vascular inflammation and reduced arterial elasticity.

Research models suggest FOXO4-DRI may support:

  • Vascular flexibility
  • Endothelial health
  • Reduced inflammatory signaling
  • Improved circulatory function

These areas continue to attract interest within cardiovascular aging research.

5. Neuroprotection and Tissue Recovery

Emerging research is also investigating the peptide's possible role in:

  • Cellular recovery
  • Tissue regeneration
  • Oxidative stress reduction
  • Neurodegenerative models

The relationship between senescence and tissue degeneration remains a major focus of regenerative medicine research.

Chemotoxicity and Cellular Protection Research

Some preclinical studies suggest FOXO4-DRI may help reduce tissue damage associated with certain chemotherapy compounds, including doxorubicin.

Research areas include:

  • Liver protection
  • Weight loss prevention
  • Cellular recovery after toxic stress
  • Reduction of chemotherapy-associated damage

Further investigation is required to better understand these mechanisms.

Regulatory Status and Research Use

FOXO4-DRI is currently classified as an investigational research peptide and is not approved by the U.S. Food and Drug Administration (FDA) or the European Medicines Agency (EMA) for medical treatment or human therapeutic use.

The peptide is supplied exclusively for:

  • Scientific research
  • Laboratory investigation
  • Experimental aging studies

Human safety data remains extremely limited, and additional long-term research is required.

⚠️ For research use only — Intended exclusively for scientific and laboratory research.

Conclusion

FOXO4-DRI remains one of the most advanced and widely discussed senolytic peptides in longevity science and regenerative research. Its ability to selectively target senescent cells has positioned it at the forefront of scientific investigations involving aging, cellular rejuvenation, and tissue regeneration.

As senolytic research continues to evolve, FOXO4-DRI remains a key compound in studies focused on healthy aging, biological resilience, and regenerative medicine.

SEO Meta Title

FOXO4-DRI Peptide | Senolytic & Longevity Research | PeptWorld

SEO Meta Description

Explore FOXO4-DRI peptide research for senolytic activity, cellular aging, neuroprotection, vascular health, and longevity science. For research use only.